GlobeNewswire 5/19 Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
GlobeNewswire 5/19 360 Privacy Expands Senior Leadership as Threats to Executives and High-Profile Individuals Grow Mor...
GlobeNewswire 5/19 Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire 5/12 Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
GlobeNewswire 5/12 Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentat...
GlobeNewswire 5/7 Ligand Reports First Quarter 2026 Financial Results
GlobeNewswire 5/6 Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Fi...
GlobeNewswire 5/6 Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Ag...
TMX Newsfile 5/5 N2Growth Named to Forbes' List of America's Best Executive Recruiting Firms for Tenth Consecutive Ye...
GlobeNewswire 4/30 FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy
GlobeNewswire 4/23 2026 HoustonCISO ORBIE Awards Recognize Top Security Executives
GlobeNewswire 4/23 Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026
GlobeNewswire 4/22 SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
GlobeNewswire 4/14 EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors
GlobeNewswire 4/9 Telix Strengthens Board with Additional Director Appointments
GlobeNewswire 4/1 Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance ...
GlobeNewswire 3/27 Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025...
GlobeNewswire 3/18 Extendicare Announces Proposed Changes to Board of Directors
GlobeNewswire 3/16 NVIDIA and Global Robotics Leaders Take Physical AI to the Real World
GlobeNewswire 3/12 Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Updat...
GlobeNewswire 3/9 Sequel Brings twiist™ Nationwide, Redefining Automated Insulin Delivery Category with Industry-First...
GlobeNewswire 3/4 Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Ac...
GlobeNewswire 3/3 Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive ...
GlobeNewswire 2/27 Anteris Reports 2025 Financial Results and Provides Corporate Update
GlobeNewswire 2/19 Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365